HSF1 and breast carcinoma: High expression of HSF1 was significantly associated with shorter overall survival (ANOVA; P = 0.00045), and relapse-free survival (ANOVA; P = 0.0057) in ER-positive breast cancer patients (Figure 3A, 3B), but not in ER-negative tumors (data not shown).